Anthroposophic medicinal products are not available as widely or as readily as would be ideal. An ECHAMP study on Homeopathic and Anthroposophic Medicinal Products in the EU found a steadily increasing demand for these products, with an annual market growth rate of 6.5% between 2010 and 2013.
A key barrier to ready supply inconsistent or outdated registration procedures for those medicines. Because regulatory rules vary by member state, the difficulty in accessing anthroposophic treatment is highly dependent on country.
The relevant legal framework set out in Article 13 and Article 16 of Directive 2001/83/EC and in Directive 2004/24/EC on Traditional Herbal Medicinal Products
ECHAMP, Homeopathic and Anthroposophic Medicinal Products in the EU, Profile of an industry, 2015.
http://ehtpa.eu/pdf/Matrix_report.pdf, Study on the Availability of Medicinal Products for Human Use, Specific Request EAHC/2001/Health/14 for the Implementation of Framework Contract EAHC/2010/Health/01 Lot 1, 21 December 2012